C. Light Technologies, Inc. is at the forefront of transforming the detection, monitoring, and treatment of multiple sclerosis (MS) and other central nervous system conditions. Their groundbreaking technology includes a patented, non-invasive retinal eye-tracker known as the tracking scanning laser ophthalmoscope (TSLO) along with advanced machine learning algorithms.
This innovative approach offers a new way to analyze and understand neurological disorders, providing valuable insights for healthcare professionals and patients alike. With IRB approval and a focus on precision and accuracy, C. Light Technologies is revolutionizing the field of neurology through cutting-edge research and development.
Generated from their website's infomation